Document Detail


Elevated left atrial pressure estimated by Doppler echocardiography is a key determinant of mitral valve tenting in functional mitral regurgitation.
MedLine Citation:
PMID:  20194204     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Functional mitral regurgitation (FMR) may occur in patients with reduced or preserved left ventricular ejection fraction (LVEF) and has been associated with excess valvular tenting only in patients with reduced LVEF. This study aimed at identifying the predictors of FMR and to determine whether or not they are different in patients with reduced versus preserved LVEF. METHODS: 190 consecutive patients free of congenital or primary valvular disease had a comprehensive echocardiographic assessment of LV remodelling and function, diastolic function and FMR severity. RESULTS: 112 patients had depressed LVEF (<50%) and 78 had preserved LVEF. FMR was present in 30 patients with preserved LVEF and in 65 with reduced LVEF. Higher E/Ea, E/A and larger mitral tenting were independent predictors of FMR regardless of LVEF. The mitral tenting area was an independent predictor of FMR severity in patients with reduced or preserved LVEF (p = 0.04 and p = 0.0045) in addition to E/A (p = 0.0007), E/Ea (p = 0.004) in patients with reduced and preserved LVEF, respectively. Higher E/Ea was independently associated with larger mitral tenting in patients with reduced and preserved LVEF. Mitral tenting area was linearly related to E/Ea (r = 0.30, p<0.0001) and E/A (r = 0.43, p<0.0001) and LA enlargement (r = 0.54, p<0.0001) after having paired 96 patients with and without FMR on indices of LV remodelling. CONCLUSIONS: In both patients with preserved and reduced LVEF, mitral tenting that leads to FMR is mainly determined by both mitral tethering forces-that is, displacement of papillary muscles and by pushing forces-that is, increased left atrial pressure. This study underscores that LV preload is a key determinant of FMR.
Authors:
S Mar?chaux; C Pin?on; M Poueymidanette; M Verhaeghe; A Bellouin; P Asseman; T Le Tourneau; T H Lejemtel; P Pibarot; P V Ennezat
Related Documents :
17684064 - The bright study: bifocal right ventricular resynchronization therapy: a randomized study.
11117394 - Myocardial high-energy phosphate metabolism is altered after treatment with anthracycli...
20337814 - Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy a...
17727984 - A young man with intractable ascites and effort dyspnoea without echocardiographic sign...
8864074 - Surgical strategy for management of deep venous thrombosis of the lower extremities.
10907624 - A taxonomy of requests by patients (torp): a new system for understanding clinical nego...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Heart (British Cardiac Society)     Volume:  96     ISSN:  1468-201X     ISO Abbreviation:  Heart     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-03-02     Completed Date:  2010-04-09     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602087     Medline TA:  Heart     Country:  England    
Other Details:
Languages:  eng     Pagination:  289-97     Citation Subset:  AIM; IM    
Affiliation:
Centre Hospitalier R?gional et Universitaire de Lille, Department of Ultrasound and Physiology, Lille, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Blood Pressure / physiology
Echocardiography, Doppler
Female
Humans
Male
Middle Aged
Mitral Valve / surgery
Mitral Valve Insufficiency / physiopathology,  surgery,  ultrasonography*
Retrospective Studies
Stroke Volume
Ventricular Dysfunction, Left / physiopathology,  ultrasonography*
Ventricular Remodeling

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rhetoric or reality? A systematic review of the impact of participatory approaches by UK public heal...
Next Document:  Childhood adversities as predictors of incident coronary heart disease and cerebrovascular disease.